SCHEMBL25201031

SCHEMBL25201031

CCNc1ncc[c]c1F

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 1/20 0.34
PGK1 P00558 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067195 0.78
SCHEMBL25188073 0.78 IL1B (0.33)
SCHEMBL2067267 0.77 PGK1 (0.35) UTS2RPGK1
SCHEMBL2067987 0.77 UTS2R (0.32) UTS2RPGK1
SCHEMBL2068577 0.73
SCHEMBL2066468 0.72 KDM4E (0.36) UTS2RPGK1KDM4E
SCHEMBL25193862 0.70 CCNE2 (0.37)
SCHEMBL2068706 0.67
SCHEMBL2067623 0.67
SCHEMBL1987052 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185588-A1 3-(1H-IMIDAZOL-2-YL)-2,3,8,8A-TETRAHYDROINDOLIZIN-5(1H)-ONE DERIVATIVES USEFUL AS FACTOR XIA INHIBITORS Janssen Pharmaceutica NV (BE) 2023-05-31 EP disclosed